baber/WOPTO huggingface dataset:
Patent CA-2186390-A1 (CA)
Title: Combinations of thrombolytically active proteins and anticoagulants, and uses thereof
Inventor: MARTIN ULRICH
IPC: A61K38/49
Filed: 1995-03-22
Abstract: The invention involves thrombolytically effective compositions and therapeutic methods. Thrombolytically active proteins are combined with anticoagulants, as long as the anticoagulant is not heparin. The anticoagulant is administered in an intravenous bolus form, while the thrombolytically active protein may be administered via intravenous bolus, or intravenous infusion.
Patent CA-2186612-A1 (CA)
Title: Star-branched acrylate and methacrylate polymers
Inventor: MISHRA MUNMAYA KUMAR
IPC: C08F297/02
Filed: 1996-01-22
Abstract: A star-branched polymer comprising a core portion and polymeric arms. The core portion is obtained by anionic polymerization of at least one unsaturated acrylate or methacrylate ester of a polyol and the polymeric arms are obtained by anionic polymerization of at least one acrylic of methacrylic monomer.
Patent CA-2188586-A1 (CA)
Inventor: BACH ALAIN
IPC: B61B12/10
Filed: 1996-10-22
Abstract: The cable car friction drive wheels (10) are spaced at regular intervals on a support beam (20) located above a station transfer rail. The cable car is coupled to a cable (12) from which it is uncoupled at entry to the station to run on rollers along the transfer rail. The cable movement, continuing to drive the friction wheels on the transfer rail, is maintained and driven by a module (19) on a cable support roller (17). The module is arranged as a caisson (21) inserted in the wheel train support beam. It comprises two axles (23,28) connected by gearing. One of the axles carries a friction wheel and the other a transmission pulley (29) for the belt transmission to the cable support.
Patent CA-2190624-A1 (CA)
Title: An implantable containment apparatus for a therapeutical device and method for loading and reloading the device therein
Inventor: BUTLER MARK D
IPC: A61K9/00
Filed: 1996-06-03
Abstract: This invention relates generally to an implantable containment apparatus made of selectively permeable material.  In particular, the implantable containment apparatus is used to contain a therapeutical device, such as a drug delivery device, a cell encapsulation device, or a gene therapy device.  A therapeutical device can be easily placed and replaced in an apparatus of the present invention without damaging tissues associated with the selectively permeable material of the apparatus.
Patent CA-2191270-A1 (CA)
Inventor: COX ROSS MITCHELL
IPC: H04M3/36
Filed: 1996-11-26
Abstract: The invention features an apparatus and method for detecting recording errors in a telephone network that provides services to a plurality of customers, the method comprising: recording information output by the telephone network relating to the provision of a service to the customers, the information having a periodic pattern; identifying disturbances in the periodic pattern that persist for longer than a predetermined time period; and generating an alarm when the identified disturbances exceed a threshold.  Th invention also features using a model to generate a forecast of information that will be output by the network in a time period that has not yet occurred utilizing information recorded during a previous time period, the model including a plurality of states representing disturbances in the periodic pattern, each state representing a disturbance having a different persistence.  The system obtains information output by the telephone network relating to the provision of the service to the customers during a time period; compares the forecast with the information obtained during the time period to generate a deviation; uses the deviation to update each of the states; and generates an alarm when a selected one of the states exceeds a threshold.
Patent CA-2192617-A1 (CA)
Title: System for manufacturing blinds
Inventor: VAN OOSTROM PETER
IPC: G05B19/418
Filed: 1996-12-11
Abstract: A system for manufacturing blinds comprises a processor unit, at least one manufacturing facility for carrying out a manufacturing step and a communication device for exchanging data between the processor unit and said at least one manufacturing facility. To arrange for efficient and economical manufacturing, whereby manufacturing time and scrap are relatively low, the processor unit is adapted to generate data for controlling the system taking into account an order portfolio and at least one parameter from said at least one manufacturing facility.
Patent CA-2193366-A1 (CA)
Inventor: TORGERSON PETER MARTE
IPC: C08F283/00
Filed: 1995-05-31
Abstract: The present invention relates to hair care compositions containing nonpolar graft thermoplastic elastomeric copolymers and a water insoluble volatile solvent for the copolymer. This invention relates to styling products such as sprays and mousses, to hair conditioning products such as rinses and leave-on conditioners, and to shampoo products useful for both cleansing and conditioning the hair.
Patent CA-2193809-A1 (CA)
Title: Modified g-protein coupled receptors
Inventor: STRADER CATHERINE D
IPC: C07K14/705
Filed: 1995-06-02
Abstract: Modified G-protein coupled receptors having deletions in the third intracellular domain are identified and methods of making the modified receptors are provided. The invention includes the modified receptors, assays employing the modified receptors, cells expressing the modified receptors, and compounds identified through the use of the modified receptors, including modulators of the receptors.
Patent CA-2194403-A1 (CA)
Title: Use of igf-i or analogues thereof in the prevention of diabetes
Inventor: THIVOLET CHARLES
IPC: A61P3/08
Filed: 1995-06-22
Abstract: The invention relates to the use of IGF-I or analogues thereof in the manufacture of a medicament useful in the prevention of diabetes, in delaying the clinical onset of diabetes and with protective effect against diabetes. It also relates to the use of IGF-I or analogues thereof in the manufacture of a medicament preventing beta cell destruction and the regulation of T cells in subjects which are at high risk of development of diabetes. The invention also relates to the method for protecting against diabetes, prevention of diabetes and delaying the clinical onset of diabetes by administration of IGF-I or analogues thereof.
Patent CA-2194411-A1 (CA)
Title: Staphylococcus aureus polynucleotides and sequences
Inventor: KUNSCH CHARLES A
IPC: C12N15/52
Filed: 1997-01-06
Abstract: The present invention provides polynucleotide sequences of the genome of Staphylococcus aureus, polypeptide sequences encoded by the polynucleotide sequences, corresponding polynucleotides and polypeptides, vectors and hosts comprising the polynucleotides, and assays and other uses thereof. The present invention further provides polynucleotide and polypeptide sequence information stored on computer readable media, and computer-based systems and methods which facilitate its use.
Patent CA-2194771-A1 (CA)
Title: Heterocyclic- and carbocyclic-substituted benzoic acids and synthesis thereof
Inventor: CHUPP JOHN PAUL
IPC: C07C315/04
Filed: 1995-07-14
Abstract: The disclosure herein relates to the title compounds of formula (I) and salts and esters thereof, wherein X is halogen, C1-6 polyhaloalkyl, C6-10 aryloxy, C1-6 alkoxy or alkylsulfonyl, C4-10 tert-alkyl, NO2 or CN; n is 0-4 and Z is an (un)substituted carbocyclic or heterocyclic ring having up to 8 ring members, said heterocyclic ring containing one or more O, N or S atom(s), in which the ring carbon substituents may be one or more X members and substituents on ring N heteroatoms may be C1-6 (halo)alkyl, hydrogen or an X  member, and synthesis thereof by catalytic oxidation of the corresponding alkyl-substituted phenylheterocyclic or carboxylic compound of formula (III) wherein X, n and Z are previously defined.
Patent CA-2195360-A1 (CA)
Title: Intravenous filter device
Inventor: RUSCHKE RICKY R
IPC: B01D63/08
Filed: 1997-01-17
Abstract: An intravenous filter device comprises a filter housing having a front side, a back side, a first end, a second end, an inlet and an outlet, the housing containing a hydrophilic filtration media and defining a flow path such that intravenous fluid entering the housing through the inlet passes through the filtration media before passing out of the housing through the outlet.  Inlet and outlet tubing connectors, both preferably attached to the front side of the filter housing, form, respectively, the housing inlet and outlet.  In the preferred embodiment the connectors are raised above the front side of the housing such that tubing connected to the connectors does not intersect the front side of the housing.  At least one vent hole in the housing provides a passageway for gas to escape from the housing, the vent hole being preferably open to the front side of the housing.  A hydrophobic membrane is positioned between the vent hole and the flow path at a position along the flow path between the inlet and the hydrophilic filtration media.  In a preferred embodiment, a tubing clip is provided to help orient the filter to make it self priming and prevent I.V. set tubing from kinking.
Patent CA-2196793-A1 (CA)
Title: Device and method for phage-based antibiotic susceptibility testing
Inventor: COTTINGHAM HUGH V
IPC: B01L3/00
Filed: 1996-06-05
Abstract: A phage-based antibiotic susceptibility test is carried out by maintaining a patient sample in a sealed well (12) during addition of the phage and Luciferin substrate used in the test, in order to prevent contamination of the laboratory environment. The phage is adhered in dried form to a metal carrier disk (26) which is retained beneath the cap (20) of the sealed sample well by means of an external magnet (24), and is mixed with the patient sample by removing the external magnet (24) and allowing the carrier disk (26) to fall to the bottom of the sample well (12). The Luciferin substrate is adhered to the underside of the cap (20) and is mixed with the patient sample by shaking or inverting the sealed sample well (12) after the metal carrier disk (26) has separated from the underside of the cap (20). A row of connected sample wells (12) and caps (20) may be employed to allow the same patient sample to be tested with multiple antibiotics.
Patent CA-2199865-A1 (CA)
Title: Collapsible pallet
Inventor: THOMAS ROGER L
IPC: B65D19/00
Filed: 1995-09-14
Abstract: A collapsible pallet (10) includes a pallet base (12) and a plurality of elongated collapsible or foldable support members (30) connected to the pallet base (12). Each of the collapsible support members (30) are foldably connected to the lower surface (16) of the pallet base (12). The collapsible pallet (10) also includes support means for maintaining the collapsible support members (30) in upright position by holding the walls of the support member (30) separate. The collapsible pallet (10) may be stored and/or transported in its collapsed configuration, and then rapidly converted to its upright position by deploying the support means. The support means may take the form of foldable support flaps (42) which fold into the support members (30), or support blocks (52) which may be inserted within the support members (30).
Patent CA-2200083-A1 (CA)
Inventor: DOLLINGER HORST
IPC: A61P19/02
Filed: 1995-09-13
Abstract: L'invention concerne de nouveaux composés de formule générale (I) et leurs sels pharmaceutiquement acceptables. Dans la formule (I), A, B, Z, R?1¿, R?2¿, R?3¿ et m ont la notation mentionnée dans la description. L'invention concerne également leurs procédés de fabrication, ainsi que des compositions pharmaceutiques contenant ces composés. Ces composés constituent de précieux antagonistes de la neurokinine (tachykinine).
Patent CA-2202554-A1 (CA)
Title: Aromatic composition on olibanam combined with a synergic agent (e.g. eucalyptol, barneol, zinc, salt, copper, salt) and use thereof
Inventor: MANNARINI AURELE
IPC: A61K33/40
Filed: 1995-10-11
Abstract: The present invention concerns the general field or aromatic compounds derived, in particular, from essential oils or plant essences. An aromatic composition comprises at least one active olibanum aromatic system consisting of, firstly, at least one olibanum essential oil and/or one or more components thereof and, secondly, at least one synergic agent selected from the compounds of formula C¿10?H¿18?0 and/or one metal selected from copper and zinc salts.
Patent CA-2205690-A1 (CA)
Inventor: GIBSON DAVID B
IPC: B65B67/12
Filed: 1997-05-20
Abstract: A removable internal support for a flexible bag made of flexible material with material memory so that the removable internal support for a flexible bag will attempt to return to a flat configuration when rolled up.  Locking apertures constrain the removable internal support for a flexible bag into a rolled-up configuration for insertion into a flexible bag. Rounded corners defined by the intersection of a bottom edge and a top edge with vertical edges, and rounded intersection corners at the intersections of the locking apertures with the vertical edges, prevent the removable internal support for a flexible bag from snagging a flexible bag in which it is installed.  The locking apertures are quickly and easily released once the removable internal support for a flexible bag is in position in the flexible bag.  After being unlocked from its rolled-up configuration, the material memory inherent in the removable internal support for a flexible bag attempts to return the removable internal support for a flexible bag toward a flat configuration, but is constrained in an approximately cylindrical shape by the flexible bag in which it is installed.  The flexible bag may then be filled, and the removable internal support for a flexible bag subsequently removed by simply pulling it out of the bag.  The flexible bag may then be tied shut and disposed of in the conventional fashions, and the removable internal support for a flexible bag is ready for re-use.
Patent CA-2206104-A1 (CA)
Title: Adamantyl substituted oxindoles as pharmaceuticals agents
Inventor: LYSSIKATOS JOSEPH PETER
IPC: A61P43/00
Filed: 1997-05-26
Abstract: This invention relates to a novel compound of the formula                        IA     or                     IB     or pharmaceutically acceptable salts thereof, wherein preferred values are as follows:  R1 is hydrogen, R2 is pyridin-4-ylmethyl, R3 is 4-pyridyl, R4 is 1- or 2-adamantyl, E1  and E2  are selected, independently, from hydrogen, halo, (C1-C3)alkyl, hydroxy, (C1-C3)alkoxy, nitro, trifluoromethyl, cyano, amino, (C1-C3)alkylamino and di[(C1-C3)alkyl]amino, and Het' and Het" are selected, independently, from 6 membered heterocyclic rings containing from one to four nitrogen atoms as part of the ring.          The invention also relates to a pharmaceutical composition for treating cancer, which composition comprises a compound as described above, or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable carrier.
Patent CA-2209712-A1 (CA)
Title: Surface modifiee pour reduire les turbulences d'un fluide et procede de transport
Inventor: ROJEY ALEXANDRE
IPC: B64C21/10
Filed: 1997-07-14
Abstract: - Structure pour inhiber les phénomènes de turbulence d'un fluide présentant une géométrie de surface comportant au moins une série de moyens d'inhibition adaptés à inhiber les turbulences présentes dans une couche limite du fluide située à proximité de la paroi de la structure, les moyens d'inhibitio n s'étendent sensiblement longitudinalement dans le sens du mouvement dudit fluide - La structure comporte au moins une première série de moyens d'amplitude a1, et au moins une seconde série de moyens d'amplitude a2. La seconde série de moyens est disposée de manière à être superposée à la première série de moyen, la première série de moyens permet d'inhiber au moins les turbulences de forte amplitude et la seconde série de moyens permet d'inhiber au moins les turbulences de faible amplitude. - Application de la structure selon l'invention pour former au moins une partie d'une conduite de transport pour un gaz sous pression.
Patent CA-2211400-A1 (CA)
Inventor: ABERG GUNNAR
IPC: A61K9/66
Filed: 1996-01-25
Abstract: A method for treating urinary incontinence while avoiding concomitant liability of adverse effects associated with racemic oxybutynin is disclosed. The method comprises administering a therapeutically effective amount of (S)-oxybutynin, (S)-desethyloxybutynin or a pharmaceutically acceptable salt thereof, substantially free of the corresponding R enantiomer. Pharmaceutical compositions in the form of tablets and transdermal devices comprising (S)-oxybutynin or (S)-desethyloxybutynin and an acceptable carrier are also disclosed, as is a synthesis of desethyloxybutynin.
Patent CA-2221154-A1 (CA)
Title: Chloroisocyanuric acid composition having reduced gas evolution
Inventor: RAGIN OSCAR T
IPC: A01N43/66
Filed: 1996-05-08
Abstract: Disclosed are trichloroisocyanuric acid compositions that have improved algicidal and/or fungicidal properties yet are relatively safe and non-corrosive. The compositions preferably contain between about 50 % and about 95 % TCCA, between about 0.5 % and about 7 % glycoluril, between about 2% and about 40 % alum, and between about 2 % and about 40 % borax. The compositions generate substantially less chlorine gas than would be expected from the teachings of the prior art, especially when wet. The inventive compositions are therefore less toxic and less corrosive.
Patent CA-2223097-A1 (CA)
Title: Improved external resonant frequency mixers based on degenerate and half-degenerate resonators
Inventor: DIXON GEORGE J
IPC: G02F1/37
Filed: 1996-05-31
Abstract: A resonator for generating frequency converted radiation from an input laser light source or sources, the resonator comprising a quantity of non-linear optical material which converts the input light to the frequency converted radiation, and an optical cavity enclosing the non-linear optical material, the cavity including optical elements disposed such that the cavity is degenerate for the transverse modes of either the frequency converted radiation or the input light.
Patent CA-2224103-A1 (CA)
Title: Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions
Inventor: MCMAHON GERALD
IPC: A61K31/40
Filed: 1996-06-05
Abstract: The present invention relates to methods and compositions for the inhibition of adaptor protein/protein tyrosine kinase protein interactions, especially wherein those interactions involving a protein tyrosine kinase capable of complexing with a member of the SH2-and/or SH3-containing family of adaptor proteins are associated with a cell proliferative disorder. Specifically, the present invention relates to particular compounds, especially quinazoline derivative compounds, and methods utilizing such compounds.
Patent CA-2224954-A1 (CA)
Title: Polycyclic iminooxadiazinediones from (cyclo) aliphatic 1,4-diisocyanates
Inventor: RICHTER FRANK
IPC: C08G18/79
Filed: 1997-12-16
Abstract: The present invention relates to polycyclic iminooxadiazinediones A corresponding to formula I     (see fig. I) The present invention also relates to mixtures of these polycyclic iminooxadiazinediones with other isocyanate derivatives and to their use for the production of optionally foamed polyurethane plastics, for the production of paints and coatings and for the production or formulation of active ingredients, pharmaceutical products, etc.
Patent CA-2227145-A1 (CA)
Title: Pates de couchage contenant des polyisocyanates
Inventor: WENDEROTH ECKHARD
IPC: C08G18/80
Filed: 1996-07-08
Abstract: L'invention concerne des pâtes de couchage améliorées, destinées notamment à la fabrication de papiers couchés et de cartons, contenant non seulement un liant synthétique mais aussi un polyisocyanate dispersible dans l'eau.
Patent CA-2230866-A1 (CA)
Inventor: YI LI
IPC: G01N33/566
Filed: 1996-04-30
Abstract: L'invention concerne des séquences de polynucléotides codant pour des allèles d'épissage du récepteur cérébral P2x4 humain. Elle concerne également l'expression recombinante desdits récepteurs et leur utilisation pour cribler des antagonistes.
Patent CA-2232888-A1 (CA)
Inventor: MEHLHORN WILLIAM L
IPC: H02P25/08
Filed: 1998-03-24
Abstract: A control circuit for controlling a switch reluctance motor including at least one phase, the control comprising a power stage including means for variably supplying a DC voltage, and a winding stage including for each phase a phase winding having one end and another end. The winding stage further includes a high voltage bus connected to the power stage, and a low voltage bus connected to the power stage. The winding stage further includes, for each phase, a first current path comprising an upper commutating switch connected to the high voltage bus, the respective phase winding one end connected to the upper switch, and a lower commutating switch connected to the respective phase winding other end and to the low voltage bus. The winding stage also includes, for each phase, a second current path comprising a first unidirectional current flow device connected to the low voltage bus and to between the upper switch and the respective phase winding one end, and a second unidirectional current flow device connected to between the respective phase winding other end and the lower switch and connected to the high voltage bus.
Patent CA-2233582-A1 (CA)
Title: Linear chimeric olgonucleotide for modulation of expression of a gene
Inventor: BENNETT CLARENCE FRANK
IPC: C07H21/00
Filed: 1994-11-07
Abstract: Genes coding for vascular cell adhesion molecules, particularly VCAM-1, are modulated through interaction of oligonucleotides with transcriptional regulatory factors which bind to the genes.  Specific and effective oligonucleotides are provided which interact with the transcriptional regulatory factors to diminish their interaction with the genes and downregulate their function.  Multi-modal oligonucleotides are also provided which interact both with a transcriptional regulatory factor and with another aspect of gene function.
Patent CA-2234087-A1 (CA)
Inventor: CLARKE ROYCE STEVEN
IPC: A47G21/12
Filed: 1996-10-10
Abstract: This invention relates to a toothpick holder and toothpicks. The toothpicks are provided in and securely attached by at least one part to a support means which provides protection on at least one end and both sides of the toothpick or toothpicks in one plane. The toothpick or toothpicks are therefore protected from damage by unintentional forces applied in those planes. The toothpick holder will generally incorporate a plurality of toothpicks, and may also include a holding means for used toothpicks and a base plate for securing the holder in a match-book-type folder. The invention also relates to particular designs of toothpicks held in the support means, said toothpicks having a substantially square or rectangular handle end and a scalpel-shaped blade end, upper and side edges of which come to a point to form the pick end.
Patent CA-2234336-A1 (CA)
Inventor: DUNCAN JOSEPH C
IPC: E04G21/22
Filed: 1998-06-04
Abstract: The entire second apparatus containing components bolted together is designed to hold motors that are made to run simultaneously or independently, and has a hydraulic system to lay a bed of mortar on a wall to be built and also has the means to keep from clogging the hose, container and cover by installing throw-away plastic liners. The apparatus has the means to travel on the existing rail system, and for a mortar tray to have the means to be raised to a desired height that a mason is comfortable with. It also has special frames when installed for a low scaffold is in place on an existing scaffold it will obtain the desire height and eliminate much of the outriggers that are now installed. Also a low dolly for placement on a rail system can dispense material where needed, also the apparatus has the means to place bricks or blocks on a bedded wall, thus eliminating many back strains.  This additional method too, is mortaring made easier.